128 related articles for article (PubMed ID: 30300532)
1. The effect of surgery on fat mass, lipid and glucose metabolism in mild primary hyperparathyroidism.
Godang K; Lundstam K; Mollerup C; Fougner F; Pernow Y; Nordenström J; Rosén T; Jansson S; Hellström M; Bollerslev J; Heck A;
Endocr Connect; 2018 Aug; 7(8):941-948. PubMed ID: 30300532
[TBL] [Abstract][Full Text] [Related]
2. Positive Effect of Parathyroidectomy Compared to Observation on BMD in a Randomized Controlled Trial of Mild Primary Hyperparathyroidism.
Lundstam K; Pretorius M; Bollerslev J; Godang K; Fagerland MW; Mollerup C; Fougner SL; Pernow Y; Aas T; Hessman O; Rosén T; Nordenström J; Jansson S; Hellström M; Heck A
J Bone Miner Res; 2023 Mar; 38(3):372-380. PubMed ID: 36593641
[TBL] [Abstract][Full Text] [Related]
3. Effects of Parathyroidectomy on Quality of Life: 10 Years of Data From a Prospective Randomized Controlled Trial on Primary Hyperparathyroidism (the SIPH-Study).
Pretorius M; Lundstam K; Hellström M; Fagerland MW; Godang K; Mollerup C; Fougner SL; Pernow Y; Aas T; Hessman O; Rosén T; Nordenström J; Jansson S; Heck A; Bollerslev J
J Bone Miner Res; 2021 Jan; 36(1):3-11. PubMed ID: 33125769
[TBL] [Abstract][Full Text] [Related]
4. Mortality and Morbidity in Mild Primary Hyperparathyroidism: Results From a 10-Year Prospective Randomized Controlled Trial of Parathyroidectomy Versus Observation.
Pretorius M; Lundstam K; Heck A; Fagerland MW; Godang K; Mollerup C; Fougner SL; Pernow Y; Aas T; Hessman O; Rosén T; Nordenström J; Jansson S; Hellström M; Bollerslev J
Ann Intern Med; 2022 Jun; 175(6):812-819. PubMed ID: 35436153
[TBL] [Abstract][Full Text] [Related]
5. Effect of Surgery Versus Observation: Skeletal 5-Year Outcomes in a Randomized Trial of Patients With Primary HPT (the SIPH Study).
Lundstam K; Heck A; Godang K; Mollerup C; Baranowski M; Pernow Y; Aas T; Hessman O; Rosén T; Nordenström J; Jansson S; Hellström M; Bollerslev J;
J Bone Miner Res; 2017 Sep; 32(9):1907-1914. PubMed ID: 28543873
[TBL] [Abstract][Full Text] [Related]
6. Effect of Parathyroidectomy on Cardiovascular Risk Factors in Primary Hyperparathyroidism: A Randomized Clinical Trial.
Ejlsmark-Svensson H; Rolighed L; Rejnmark L
J Clin Endocrinol Metab; 2019 Aug; 104(8):3223-3232. PubMed ID: 30860588
[TBL] [Abstract][Full Text] [Related]
7. Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy.
Piovesan A; Molineri N; Casasso F; Emmolo I; Ugliengo G; Cesario F; Borretta G
Clin Endocrinol (Oxf); 1999 Mar; 50(3):321-8. PubMed ID: 10435057
[TBL] [Abstract][Full Text] [Related]
8. Mild primary hyperparathyroidism: vitamin D deficiency and cardiovascular risk markers.
Farahnak P; Lärfars G; Sten-Linder M; Nilsson IL
J Clin Endocrinol Metab; 2011 Jul; 96(7):2112-8. PubMed ID: 21593116
[TBL] [Abstract][Full Text] [Related]
9. Factors influencing insulin sensitivity in patients with mild primary hyperparathyroidism before and after parathyroidectomy.
Almqvist EG; Bondeson AG; Bondeson L; Mellström D; Svensson J
Scand J Clin Lab Invest; 2012 Apr; 72(2):92-9. PubMed ID: 22106852
[TBL] [Abstract][Full Text] [Related]
10. The influence of parathyroidectomy on cardiometabolic risk factors in patients with primary hyperparathyroidism: a systematic review and meta-analysis.
Yavari M; Feizi A; Haghighatdoost F; Ghaffari A; Rezvanian H
Endocrine; 2021 Apr; 72(1):72-85. PubMed ID: 33057988
[TBL] [Abstract][Full Text] [Related]
11. Metabolic abnormalities in patients with normocalcemic hyperparathyroidism detected at a population-based screening.
Hagström E; Lundgren E; Rastad J; Hellman P
Eur J Endocrinol; 2006 Jul; 155(1):33-9. PubMed ID: 16793947
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trial.
Rolighed L; Rejnmark L; Sikjaer T; Heickendorff L; Vestergaard P; Mosekilde L; Christiansen P
J Clin Endocrinol Metab; 2014 Mar; 99(3):1072-80. PubMed ID: 24423366
[TBL] [Abstract][Full Text] [Related]
13. Prediction of bone mass change after parathyroidectomy in patients with primary hyperparathyroidism.
Nakaoka D; Sugimoto T; Kobayashi T; Yamaguchi T; Kobayashi A; Chihara K
J Clin Endocrinol Metab; 2000 May; 85(5):1901-7. PubMed ID: 10843172
[TBL] [Abstract][Full Text] [Related]
14. Effect of Parathyroidectomy Upon Left Ventricular Mass in Primary Hyperparathyroidism: A Meta-Analysis.
McMahon DJ; Carrelli A; Palmeri N; Zhang C; DiTullio M; Silverberg SJ; Walker MD
J Clin Endocrinol Metab; 2015 Dec; 100(12):4399-407. PubMed ID: 26445115
[TBL] [Abstract][Full Text] [Related]
15. Serum erythropoietin and erythropoiesis in primary and secondary hyperparathyroidism: effect of parathyroidectomy.
Ureña P; Eckardt KU; Sarfati E; Zingraff J; Zins B; Roullet JB; Roland E; Drüeke T; Kurtz A
Nephron; 1991; 59(3):384-93. PubMed ID: 1758526
[TBL] [Abstract][Full Text] [Related]
16. Effect of parathyroidectomy on epicardial fat thickness as a cardiovascular risk factor in patients with primary hyperparathyroidism.
Kızılgül M; Çalışkan M; Beysel S; Özbek M; Çakal E
Turk J Med Sci; 2019 Aug; 49(4):1165-1169. PubMed ID: 31385484
[TBL] [Abstract][Full Text] [Related]
17. Bone mineral density evolution after successful parathyroidectomy in patients with normocalcemic primary hyperparathyroidism.
Koumakis E; Souberbielle JC; Sarfati E; Meunier M; Maury E; Gallimard E; Borderie D; Kahan A; Cormier C
J Clin Endocrinol Metab; 2013 Aug; 98(8):3213-20. PubMed ID: 23783096
[TBL] [Abstract][Full Text] [Related]
18. Tertiary hyperparathyroidism in kidney transplant recipients: characteristics of patients selected for different treatment strategies.
Yang RL; Freeman K; Reinke CE; Fraker DL; Karakousis GC; Kelz RR; Doyle AM
Transplantation; 2012 Jul; 94(1):70-6. PubMed ID: 22706321
[TBL] [Abstract][Full Text] [Related]
19. Health-related quality of life after successful surgery for primary hyperparathyroidism: no additive effect from vitamin D supplementation: results of a double-blind randomized study.
Åberg V; Norenstedt S; Zedenius J; Sääf M; Nordenström J; Pernow Y; Nilsson IL
Eur J Endocrinol; 2015 Feb; 172(2):181-7. PubMed ID: 25414430
[TBL] [Abstract][Full Text] [Related]
20. Changes in blood pressure and renal function following subtotal parathyroidectomy in renal transplant patients presenting with persistent hypercalcemic hyperparathyroidism.
Rostaing L; Moreau-Gaudry X; Baron E; Cisterne JM; Monroziès-Bernadet P; Durand D
Clin Nephrol; 1997 Apr; 47(4):248-55. PubMed ID: 9128792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
